18311-26-7

Basic information

• Product Name: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE
• Synonyms: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE;Methyl-6-O-trityl-alpha-D-glucopyranoside
• CAS NO: 18311-26-7
• Molecular Formula: C₂₆H₂₈O₆
• Molecular Weight: 436.5
• Mol File: 18311-26-7.mol
• Article Data: 74

Chemical Properties

• Melting Point: 153-154 °C(Solv: ethanol (64-17-5))
• Boiling Point: 593.3°Cat760mmHg
• Flash Point: 312.6°C
• Appearance: /
• Density: 1.3g/cm³
• Vapor Pressure: 6.37E-15mmHg at 25°C
• Refractive Index: 1.641
• PKA: 12.89±0.70(Predicted)
• CAS DataBase Reference: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE(18311-26-7)
• EPA Substance Registry System: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE(18311-26-7)

Safety Data

• Hazardous Substances Data: 18311-26-7(Hazardous Substances Data)

Usage

General Description

METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE is a chemical compound that is a derivative of glucose. It is a methylated alpha-D-glucopyranoside with a triphenylmethyl group attached to the sixth carbon of the glucose ring. METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-GLUCOPYRANOSIDE has various uses in organic synthesis and as a chemical reagent in laboratory experiments. It is often used as a protecting group for the hydroxyl groups on glucose molecules, as well as in the synthesis of complex carbohydrates and other bioactive compounds. Additionally, it can serve as a useful tool in studying carbohydrate-protein interactions and other biochemical processes.

InChI:InChI=1/C26H28O6/c1-30-25-24(29)23(28)22(27)21(32-25)17-31-26(18-11-5-2-6-12-18,19-13-7-3-8-14-19)20-15-9-4-10-16-20/h2-16,21-25,27-29H,17H2,1H3

Upstream product

• 76-83-5 trityl chloride 
• 3396-99-4 methyl α-D-galactopyranoside 
• 1824-94-8 methyl beta-D-galactopyranoside 
• 97-30-3 methyl-alpha-D-glucopyranoside 
• 604-70-6 Acetic acid (2R,3R,4S,5R,6S)-3,5-diacetoxy-2-acetoxymethyl-6-methoxy-tetrahydro-pyran-4-yl ester 
• 100-52-7 benzaldehyde 
• 492-62-6 alpha-D-glucopyranose 
• 81788-19-4 (2R,3S,4S,5R,6S)-6-Methoxy-5-trityloxy-2-trityloxymethyl-tetrahydro-pyran-3,4-diol 
• 86172-75-0 (2S,3R,4R,5S,6R)-2-Methoxy-5-trityloxy-6-trityloxymethyl-tetrahydro-pyran-3,4-diol 
• 86179-47-7 2,6-di-O-trityl-α-D-glucopyranoside 
• 87591-35-3 Methyl 2,3,4-tri-O-acetyl-6-O-trityl-β-D-galactopyranoside 
• 86172-84-1 (2R,3R,4S,5R,6S)-6-Methoxy-5-trityloxy-2-trityloxymethyl-tetrahydro-pyran-3,4-diol 
• 86172-85-2 methyl 3,6-di-O-trityl-α-D-galactopyranoside 
• 53685-07-7 Methyl 3,4-O-isopropylidene-6-O-triphenylmethyl-α-D-galactopyranoside 

Downstream Products

• 18685-19-3 methyl 2,3,4-tri-O-benzyl-6-O-trityl-α-D-galactopyranoside 
• 40653-30-3 methyl 2,3,4-tri-O-benzyl-6-O-triphenylmethyl-β-D-galactopyranoside 
• 34698-24-3 methyl 3,4-O-isopropylidene-6-O-trityl-β-D-galactopyranoside 
• 176495-63-9 (2S,3R,4S,5R,6R)-3,4,5-Tributoxy-2-methoxy-6-trityloxymethyl-tetrahydro-pyran 
• 131511-70-1 (3aR,4R,6S,7R,7aR)-6-Methoxy-2,2,2-triphenyl-4-trityloxymethyl-tetrahydro-1,3,5-trioxa-2λ⁵-phospha-inden-7-ol 
• 131511-69-8 (3aR,4S,6R,7R,7aS)-4-Methoxy-2,2,2-triphenyl-6-trityloxymethyl-tetrahydro-1,3,5-trioxa-2λ⁵-phospha-inden-7-ol 
• 7511-40-2 methyl 2,3,4-tri-O-acetyl-6-O-trityl-α-D-glucopyranoside 
• 2595-06-4 methyl 2,3,4-tri-O-benzyl-6-O-trityl-α-D-glucopyranoside 
• 77988-11-5 methyl 2,4-di-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside 
• 120026-82-6 methyl 2,3,4-tri-O-allyl-6-O-trityl-α-D-glucopyranoside 
• 137897-37-1 methyl 2,3,4-tri-O-(p-methoxyphenylmethyl)-6-O-trimethylphenyl-1-α-D-glucopyranoside 
• 6984-43-6 (2S,3R,4S,5R,6R)-2,3,4,5-tetramethoxy-6-((trityloxy)methyl)tetrahydro-2H-pyran 
• 87585-97-5 Methyl 4-Deoxy-4-fluoro-6-O-trityl-α-D-galactopyranoside 
• 87586-00-3 Methyl 4-deoxy-4-fluoro-6-O-trityl-α-D-galactopyranoside 

Relevant articles and documents

Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei

Sugar derivatives mimicking compounds which take part in the catalysed reaction have been assayed as alternative substrates and/or competitive inhibitors of 6-phosphogluconate dehydrogenase from Trypanosoma brucei and sheep liver. Phosphonate analogues ha

Ring-opening polymerization of lactones using binaphthyl-diyl hydrogen phosphate as organocatalyst and resulting monosaccharide functionalization of polylactones

Binaphthyl-diyl hydrogen phosphate has been assessed for the first time as a catalyst for the ring-opening polymerization of ε-caprolactone (CL) and δ-valerolactone (VL). In the presence of benzyl alcohol as coinitiator at 40-60 °C, the polymerization is

Peptide-Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells

Peptide-stabilized platinum nanoparticles (PtNPs) were developed that have significantly greater toxicity against hepatic cancer cells (HepG2) than against other cancer cells and non-cancerous liver cells. The peptide H-Lys-Pro-Gly-dLys-NH2 was identified by a combinatorial screening and further optimized to enable the formation of water-soluble, monodisperse PtNPs with average diameters of 2.5 nm that are stable for years. In comparison to cisplatin, the peptide-coated PtNPs are not only more toxic against hepatic cancer cells but have a significantly higher tumor cell selectivity. Cell viability and uptake studies revealed that high cellular uptake and an oxidative environment are key for the selective cytotoxicity of the peptide-coated PtNPs.

-

-

Chemoenzymatic synthesis of 3-deoxy-3-fluoro-l-fucose and its enzymatic incorporation into glycoconjugates

The first synthesis of 3-deoxy-3-fluoro-l-fucose is presented, which employs ad- tol-sugar translation strategy, and involves an enzymatic oxidation of 3-deoxy-3-fluoro-l-fucitol. Enzymatic activation (FKP) and glycosylation using an α-1,2 and an α-1,3 fu

Chemical synthesis and preliminary biological evaluation of C-6-O-methyl-1-deoxynojirimycin as a potent α-glucosidase inhibitor

A facile and efficient synthesis of 6-O-methyl-1-deoxynojirimycin 4 from commercially available methyl α-D-glucopyranoside in 10 steps and 25% overall yield was reported. The synthetic strategy was based on the regioselective protection/deprotection at 6-